Exelixis, Inc. (EXEL)
41.33
-0.50
(-1.20%)
USD |
NASDAQ |
Mar 18, 12:34
Exelixis EPS Diluted (Quarterly) : 0.8849 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Natera, Inc. | 0.3383 |
| Merck & Co., Inc. | 1.191 |
| Castle Biosciences, Inc. | -0.0795 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Bio-Techne Corp. | 0.2421 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 244.53M |
| Revenue (Quarterly) | 598.66M |
| Total Expenses (Quarterly) | 354.14M |
| Enterprise Value | 10.01B |
| Gross Profit Margin (Quarterly) | 95.58% |
| Profit Margin (Quarterly) | 40.85% |
| Earnings Yield | 6.74% |
| Operating Earnings Yield | 7.66% |
| Normalized Earnings Yield | 6.860 |